NCT00620308View on ClinicalTrials.gov

CD-NP in Subjects With Stable Chronic Heart Failure

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Stable Chronic Heart Failure
Interventions
DRUG

CD-NP

One of two dosage levels (20 ng/kg/min and another level to be finalized) as a continuous intravenous infusion for four hours

DRUG

Placebo

Dextrose 5% in water (the vehicle)

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER